• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II AUI STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II AUI STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETUF3214C102EE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Low Blood Pressure/ Hypotension (1914); Tachycardia (2095); Multiple Organ Failure (3261)
Event Date 02/28/2020
Event Type  Death  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
An endurant bifurcate stent graft system was implanted in an unknown endovascular treatment.It was reported that the patient presented emergently 9 years and 4 months later in deep shock.A cta was performed which had the conclusion that there was active retroperitoneal bleeding based on a undetermined type iii endoleak (rszight side just cranial of the bifurcation of the prosthesis).The aneurysm ruptured due to the type iii endoleak.The patient was emergently brought to or in shock (tension of 40mmhg, temperature 35 degrees).An aorto-uni-iliac prosthesis was implanted to the right leg and a fem-fem crossover to the left leg was performed.During that night the patient was tachycardiac and hypotensive and in discomfort.They became increasingly more hemodynamically unstable.It was then reported that because of this, all treatment and medication was stopped and the patient was extubated.The patient expired shortly after the treatment ceasing.The sponsor and the site assessed the event as related to the endurant device and not related to the procedure.No additional clinical sequelae were provided and the patient is expired.
 
Manufacturer Narrative
Sponsor assessed the rupture to be related to the device and related to the procedure.Site assessed type iii endoleak to be related to the device and not related to the procedure.Sponsor assessed type iii endoleak to be related to the device and not related to the procedure.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
It was confirmed on both the cta and angiography that the endoleak appeared to be a type iiib (tear) of the bifurcate main body stent graft.The patient died of multiorgan failure after deep hypovolemic shock pre-operatively.The cause of the event can not be determined.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II AUI STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
091708096
MDR Report Key9805110
MDR Text Key182533548
Report Number9612164-2020-01074
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 07/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/17/2020
Device Model NumberETUF3214C102EE
Device Catalogue NumberETUF3214C102EE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/05/2020
Initial Date FDA Received03/09/2020
Supplement Dates Manufacturer Received03/17/2020
06/25/2020
Supplement Dates FDA Received04/10/2020
07/23/2020
Date Device Manufactured09/18/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age80 YR
Patient Weight110
-
-